PLASMOLIFTING™ MINI DRY BATH INCUBATOR 100
Sorry, this item is out of stock
Platelet-rich plasma (PRP) is often used in medicine and surgery, particularly in orthopedics, traumatology, oral and maxillofacial surgery, plastic surgery, reconstructive surgery and ophthalmology. Having bio-regenerating and bio-stimulating properties, PRP is also used in regenerative medicine to accelerate the healing process of ulcers and burns. In aesthetic medicine, it helps to minimize the signs of aging on mature skin, helping to slow physiological aging. Plasmogel can be prepared from PRP through heating. After being thermally process, PRP will form a viscous gel (which can be injected superperiostally or intradermally). Thanks to its homogenous distribution, Plasmogel does not leave a visible trace (or cause side effects for that matter). Plasmogel has many uses in aesthetic medicine. This includes volume restoration in the middle face, correction of the facial contour, treatment of wrinkles (perioral, nasolabial, periocular and forehead), skin rejuvenation and facial support. It is also indicated for the treatment of skin laxity and acne scars. Order Plasmolifting Incubator Mini B 100 from Medical Device Source to obtain Plasmogel.
Plasmolifting Incubator Mini B 100 is basically a heating block controlled by a microprocessor. It is often used to thermally process platelet-rich plasma (otherwise known as PRP). This incubator is specially designed for the second step of the Plasmolifting treatment. It is able to heat centrifuged PRP up to a temperature of 95 degree Celsius, thereby forming the viscous Plasmogel. For best results, heat the PRP for six minutes. Part of the Plasmolifting family, the incubator is often used along with other equipment such as Plasmolifting tubes, luer-lock syringes, needles (for gel injection) and a centrifuge (e.g. Plasmolifting Centrifuge XC 2000).
Through the liquid crystal display (LCD) screen, users can view the temperature and time. The smart Plasmolifting Incubator Mini B 100 has a built-in over-temperature protection function, which alerts the user when the temperature is abnormally high. Apart from that, the incubator also has a fault detection function where it triggers the buzzer alarm when the device is not functioning correctly. Thanks to its light and portable design, Plasmolifting Incubator Mini B 100 can be easily carried around. The incubator requires a direct current (DC) of 24V to operate. It is advisable to disinfect and clean the machine on a regular basis (make sure that Plasmolifting Incubator Mini B 100 is not connected to a power source while doing so). Prior to use, it is recommended to perform temperature calibration. For more information on how to use Plasmolifting Incubator Mini B 100, refer to the user manual. Contact the manufacturer if you have any questions.
Plasmolifting Incubator Mini B 100 comes in two different models: 100 F and 100 L. The 100 F model has a fan to help dissipate heat (allowing for a more rapid temperature drop). Plasmolifting Incubator Mini B 100 L, on the other hand, is manufactured using the patented Thermo Cover technology. This helps to prevent the content from being evaporated. The cooling types have a semiconductor for refrigeration, whereas the heating types consist of a heater. Plasmolifting Incubator Mini B 100 is a product of Industrie Biomediche e Farmaceutiche, a company headquartered in Scafati, Italy.
In most cases, Plasmogel will remain in the tissue for about three months (this may vary from patient to patient). Notably, the tissue regenerating effects of Plasmogel can last for a much longer period of time. Two weeks after the initial treatment, Plasmogel treatment can be repeated if needed.
Plasmolifting Incubator Mini B 100 is assembled in Italy in accordance with stringent quality standards. The machine itself is not likely to cause major complications, as long as all precautions are observed. As with all therapeutic devices, it is important to read the user’s manual before using Plasmolifting Incubator Mini B 100. Although the incubator is generally safe, PRP treatment can potentially cause injection-site reactions such as infection, pain, inflammation, and swelling. These reactions are commonly associated with cutaneous regenerating procedures that involve infiltration (or injection for that matter). At the same time, the plasmatic components have a risk of causing symptoms such as tenderness, bruising, swelling, redness and itching. Some patients may also develop pustules after the administration of PRP. These adverse effects are usually mild and self-limiting, which means they will resolve themselves without any treatment.
As a safety precaution, PRP should be used carefully in certain patients (for example, those with HIV infection or abnormal platelet functions). Additionally, PRP should be used cautiously in patients who have acute or chronic infection at the treatment area. Plasmolifting treatment may not be suitable for individuals with diabetes, thyroid disease, osteomalacia disease, neoplastic disease, immunodeficiency, renal and liver diseases, autoimmune disease, degenerative disease, neoplastic disease, immunodeficiency and acute herpes infections (proceed with caution). It is not known if PRP is safe in children who have not reached skeletal maturity (or pregnant patients). On the other hand, Plasmogel is contraindicated in patients who have mental illness, systemic blood diseases or malignant neoformations. Furthermore, the use of Plasmogel is contraindicated in those who have previously had allergic reactions to sodium heparin (an anticoagulant).
If you want to prepare Plasmogel, purchase Plasmolifting Incubator Mini B 100 from Medical Device Source.